胃幽門桿菌檢驗的全球市場 - 市場規模(各市場區隔)，佔有率，法規，償付，預測(～2033年)

本報告提供全球胃幽門桿菌檢驗市場相關調查分析，提供各市場區隔的市場規模，市場趨勢，競爭情形，COVID-19影響等資訊。

市場模式的主要內容如下列。

已上市的胃幽門桿菌檢驗與不斷變化的競爭格局

• 主要的產業趨勢考察
• 胃幽門桿菌檢驗市場區隔的年度收益和市場預測(2015年～2033年)
• 台數，平均銷售價格，市場金額相關市場層級的資料

世界，地區，國家層級的市場固有考察

• 各地區分類的全球趨勢之定性市場固有資訊與各國考察
• 胃幽門桿菌檢驗市場SWOT分析
• 胃幽門桿菌檢驗市場競爭動態的考察和趨勢

透過掌握包含醫療制度概要的真實整體狀況來促進對市場的認識。此外在打入市場部門更提供關於給付原則及法規情勢之資訊，使您能夠更深入地研究市場動態。

• 各國醫療制度概要
• 各國償付政策
• 各國醫療技術相關法規形勢

對象企業

• Avanos Medical Inc
• Meridian Bioscience Inc
• DiaSorin SpA
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc
• bioMerieux SA
• Bio-Rad Laboratories Inc,Siemens AG
• Trinity Biotech Plc
• Merck KGaA
• Sekisui Chemical Ltd
• Sentinel CH. SpA
• Abbott Laboratories
• Quidelortho Corp
• TECHLAB Inc
• Agilent Technologies Inc
• Cardinal Health Inc
• Biocare Medical LLC
• Danaher Corp
• Werfen Life Group SAU
• MP Biomedicals LLC
• GI Supply Inc
• Serim Research Corporation
• Beckman Coulter Inc
• Polymedco Inc
• 其他

Abstract

Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Helicobacter Pylori Tests market for the year 2020 and beyond. The Helicobacter Pylori Tests include Helicobacter pylori Breath Test, Helicobacter pylori Feces Test, Helicobacter pylori Serology EIA Test, Helicobacter pylori Rapid Urease Test, Helicobacter pylori Immunohistochemical Test and Helicobacter pylori(POC) Tests.

Peptic Ulcer Disease (PUD) is a break in the lining of the stomach, first part of small intestine and lower oesophagus occasionally. An ulcer in the stomach is also known as gastric ulcer, and an ulcer in the first part of the intestine is called a duodenal ulcer. Peptic ulcer is a chronic disease affecting up to 10% of the world's population.

H. pylori plays a predominant role in the etiology of GC and was characterized as a class I carcinogen by the World Health Organisation. The oncogenic effects of H. pylori can occur through a variety of mechanisms, including the indirect inflammatory effects of H. pylori on the gastric mucosa and the direct epigenetic effects of H. pylori on individual cells. Other indications include Dyspepsia and Gastric MALT Lymphoma.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Helicobacter Pylori Tests and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Helicobacter Pylori Tests market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Helicobacter Pylori Tests market.
• Competitive dynamics insights and trends provided for Helicobacter Pylori Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Avanos Medical Inc, Meridian Bioscience Inc, DiaSorin SpA, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, bioMerieux SA, Bio-Rad Laboratories Inc,Siemens AG, Trinity Biotech Plc, Merck KGaA, Sekisui Chemical Ltd, Sentinel CH. SpA, Abbott Laboratories, Quidelortho Corp, TECHLAB Inc, Agilent Technologies Inc, Cardinal Health Inc, Biocare Medical LLC, Danaher Corp, Werfen Life Group SAU, MP Biomedicals LLC, GI Supply Inc, Serim Research Corporation, Beckman Coulter Inc, Polymedco Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Helicobacter Pylori Tests market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Helicobacter Pylori Tests market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Helicobacter Pylori Tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Helicobacter Pylori Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Helicobacter Pylori Tests market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable